- Home
- AXR vs THTX Comparison
AXR vs THTX Comparison
Compare AXR & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXR
- THTX
- Stock Information
- Founded
- AXR 1961
- THTX 1993
- Country
- AXR United States
- THTX Canada
- Employees
- AXR N/A
- THTX N/A
- Industry
- AXR Homebuilding
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- AXR Real Estate
- THTX Health Care
- Exchange
- AXR Nasdaq
- THTX Nasdaq
- Market Cap
- AXR 114.8M
- THTX 119.1M
- IPO Year
- AXR N/A
- THTX N/A
- Fundamental
- Price
- AXR $23.62
- THTX $3.15
- Analyst Decision
- AXR
- THTX Hold
- Analyst Count
- AXR 0
- THTX 1
- Target Price
- AXR N/A
- THTX N/A
- AVG Volume (30 Days)
- AXR 14.9K
- THTX 1.0M
- Earning Date
- AXR 07-22-2025
- THTX 07-09-2025
- Dividend Yield
- AXR N/A
- THTX N/A
- EPS Growth
- AXR 472.07
- THTX N/A
- EPS
- AXR 2.41
- THTX N/A
- Revenue
- AXR $58,052,000.00
- THTX $84,378,000.00
- Revenue This Year
- AXR $120,108.69
- THTX N/A
- Revenue Next Year
- AXR $8.16
- THTX $15.13
- P/E Ratio
- AXR $9.87
- THTX N/A
- Revenue Growth
- AXR 30.35
- THTX 2.19
- 52 Week Low
- AXR $17.60
- THTX $1.12
- 52 Week High
- AXR $39.68
- THTX $3.20
- Technical
- Relative Strength Index (RSI)
- AXR 67.84
- THTX 73.35
- Support Level
- AXR $20.85
- THTX $2.28
- Resistance Level
- AXR $24.21
- THTX $3.20
- Average True Range (ATR)
- AXR 1.15
- THTX 0.07
- MACD
- AXR 0.29
- THTX 0.08
- Stochastic Oscillator
- AXR 72.99
- THTX 94.79
About AXR AMREP Corporation
Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.